Skip to main content

Day: May 20, 2021

Atea Pharmaceuticals Appoints Jerome Adams, M.D., M.P.H., to Board of Directors

Former U.S. Surgeon General Brings Wealth of Clinical and Public Health Experience BOSTON, May 20, 2021 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe viral infections, today announced the appointment of Jerome Adams, M.D., M.P.H., to its Board of Directors. Dr. Adams most recently served as Surgeon General of the United States and brings a wide range of experience spanning clinical practice, clinical research, public health, and government agency leadership. “We are honored to welcome Dr. Adams to our Board of Directors, as his unique experience as Surgeon General during the COVID-19 pandemic will undoubtedly help guide Atea as we continue to advance our antiviral pipeline, including our global Phase 3 MORNINGSKY trial...

Continue reading

Brookfield Asset Management Announces Renewal of Normal Course Issuer Bid

BROOKFIELD, NEWS, May 20, 2021 (GLOBE NEWSWIRE) — Brookfield Asset Management Inc. (NYSE: BAM) (TSX: BAM.A) today announced it has received approval from the Toronto Stock Exchange (“TSX”) for the renewal of its normal course issuer bid to purchase up to 132,856,682 Class A Limited Voting Shares (“Class A Shares”), representing 10% of the public float of Brookfield’s outstanding Class A Shares. Purchases under the bid will be made through the facilities of the TSX, the New York Stock Exchange (“NYSE”), and/or alternative trading systems. The period of the normal course issuer bid will extend from May 25, 2021 to May 24, 2022, or an earlier date should Brookfield complete its purchases. Brookfield will pay the market price at the time of acquisition for any Class A Shares purchased or such other price as may be permitted. As at...

Continue reading

U.S. Welding Consumables Market to Reach USD 3.35 Billion by 2028; High Demand for Welding Solutions from Shipbuilding and Railway Industries to Propel Growth: Fortune Business Insights™

List of the Companies Profiled in the Market: The Lincoln Electric Company,KISWEL CO.LTD,KOBE STEEL.LTD,Colfax Corporation,Illinois Tool Works Inc.,Fronius International GmbH,Hyundai Welding Co., Ltd.Linde plc,CS HOLDINGS LTD,Miller Electric Mfg. LLC,Selectrode Industries, Ltd.Obara Corporation,ARCON Welding,Welding Alloy Group,DENYO,Hobart Welding Products. Pune, India, May 20, 2021 (GLOBE NEWSWIRE) — The U.S. welding consumables market is set to gain momentum from the need to reduce the weight of vehicles. Hence, manufacturers are employing fabric materials instead of metal parts to minimize sound pollution, lower emissions, and fuel consumption. Lincoln Electric, for instance, unveiled GTAW (TIG) cut lengths in September 2019. These would enable high-quality, clean welds with reduced welding fume and spatter. This information...

Continue reading

Golar releases its 2020 Environmental, Social and Governance report

Golar LNG Limited (“Golar” or “the Company”) is pleased to announce that it has issued its 2020 Environmental, Social and Governance report. This comprehensive report describes the Company’s important role in advancing the global energy transition to a lower carbon future – championing LNG as a transitional fuel in partnership with renewables, maintaining efficient and responsible operations, and supporting the development of carbon free fuels. The report, which details performance across key focus areas of Health, Safety & Security; Environmental Impact; Innovation & Transition; People & Communities; and Governance & Ethics, also describes our range of targets for 2030. Developed in consultation with internal and external stakeholders, our ambitions include:Sustain a lost-time injury frequency below 0.8 (per...

Continue reading

Endeavour Silver Drilling Intersects High-Grade Gold-Silver Mineralization at the Bolanitos Mine in Durango, Mexico

VANCOUVER, British Columbia, May 20, 2021 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (TSX: EDR, NYSE: EXK) has intersected high grade gold-silver mineralization in its 2021 exploration drill program to expand the Melladito and Belen orebodies at the Bolañitos Mine in Guanajuato State, Mexico.   The Company is currently producing from four orebodies at Bolañitos: Plateros, Lucero, San Miguel and Melladito. Exploration drilling is ongoing along the Melladito and Belen veins (view longitudinal sections here). Highlights from the latest drill results include:8.09 grams per tonne (gpt) gold and 1,044 gpt silver for 1,611 gpt silver equivalent (AgEq at an 70:1 silver:gold ratio) over a 1.0 metre (m) true width (47.0 oz per short ton (opT) AgEq over 3.3 feet (ft)), including 14.2 gpt gold and 1,974 gpt silver for 2,966 gpt AgEq over...

Continue reading

InterCure Acquires One of Israel’s Leading Active Medical Cannabis Trade Houses & Initiates Special Home Delivery Service in Collaboration With UPS

Acquisition of one of the leading active, IMCA approved trade houses in Israel expanding InterCure’s sales channel, distribution, delivery and storage capacity. As part of the acquisition, two additional pharmacies added to Intercure’s leading medical focused, pharmacy chain Acquisition expected to be accretive from Q3 2021 empowering InterCure to further boost growth and profits InterCure initiated a special medical cannabis home delivery program in collaboration with UPS – supporting Israel’s patients‘ community solid demand TORONTO and HERZLIYA, Israel, May 20, 2021 (GLOBE NEWSWIRE) — InterCure Ltd. (TSX: INCR:U, TASE: INCR)(dba Canndoc)(“InterCure” or the “Company”) today announced that it signed a definitive agreement to acquire a licensed active medical cannabis trading house and two pharmacies. The...

Continue reading

Ehave KetaDASH Subsidiary Commences Data Collection for Potential Patients and Partnering Clinics

Brings Ketamine treatments for anxiety, depression and PTSD to the home; Supports Ketamine clinics and mental health professionals. MIAMI, May 20, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its KetaDASH subsidiary has commenced data collection for potential patients and partnering clinics. KetaDASH, which is a HIPAA compliant, cloud based platform, will be first to market as a home healthcare provider offering IV based infusion therapy of ketamine. KetaDASH is available to ketamine clinics and qualified patients whose healthcare provider has prescribed it as a treatment. Qualified patients, doctors, and clinics are invited to visit https://www.ketadash.com/sign-up/ for more information. KetaDASH has designed...

Continue reading

QIWI Announces First Quarter 2021 Financial Results

First Quarter Total Net Revenue Decreases 18% to RUB 5,161 Million and Adjusted Net Profit Increases 18% to RUB 2,061 Million or RUB 33.00 per diluted shareQIWI reiterates 2021 GuidanceBoard of Directors Approves Dividends of 22 cents per share NICOSIA, Cyprus, May 20, 2021 (GLOBE NEWSWIRE) — QIWI plc (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”) today announced its financial results for the first quarter ended March 31, 2021. First Quarter 2021 Operating and Financial HighlightsTotal Net Revenue decreased 18% to RUB 5,161 million ($68.2 million) Payment Services Segment Net Revenue decreased 11% to RUB 4,762 million ($62.9 million) Adjusted EBITDA increased 23% to RUB 2,820 million ($37.3 million) Adjusted Net Profit increased 18% to RUB 2,061 million ($27.2 million), or RUB 33.00 per diluted share Payment Services Segment...

Continue reading

LAVA Therapeutics Provides Business Update and Reports First Quarter Financial Results

IPO bolsters balance sheet to $160 million in cash and cash equivalents; expected to fund operations at least into the second half of 2023 Clinical development plans on schedule in both hematological and solid tumor programs Leadership strengthened through key management and board appointments UTRECHT, The Netherlands and PHILADELPHIA, May 20, 2021 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in gamma-delta bispecific T cell engagers (bsTCEs) to transform cancer therapy, today reported its business update and first quarter 2021 financial results. “We continue to make important strides across all aspects of our business as we transition to a clinical stage organization,” said Stephen Hurly, chief executive officer of LAVA Therapeutics. “With the recent additions...

Continue reading

Xunlei Announces Unaudited Financial Results for the First Quarter Ended March 31, 2021

SHENZHEN, China, May 20, 2021 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading innovator in shared cloud computing and blockchain technology in China, today announced its unaudited financial results for the first quarter ended March 31, 2021. First Quarter 2021 Financial Highlights:Total revenues were US$53.3 million, representing an increase of 5.9% from the previous quarter.Cloud computing and other internet value-added services (“Cloud computing and other IVAS”) revenues were US$27.3 million, representing an increase of 5.7% from the previous quarter.Subscription revenues were US$22.1 million, representing an increase of 6.9% from the previous quarter.Online advertising revenues (consisting primarily of revenues from mobile advertising) were US$3.9 million, representing an increase...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.